ABSTRACT
Family resilience is defined as family members successfully coping with difficulties and developing with warmth, support and harmony. This structure can be affected by the forces, resources and processes of the individuals that make up the family. Current studies emphasize many risk factors that affect and force family dynamics with the introduction of the coronavirus pandemic into our lives. The results of these studies suggest that although the origin of worldwide anxiety is one, different families have different coping styles. Starting from this point, the aim of this study, which is planned, is to determine how families protect their health in the coronavirus pandemic, which is over one year. 580 married mothers participated in the study. Participants answered the demographic information form, Risk Factors Checklist and Family Resilience Scale. The findings obtained from the study are that family resilience shows significant differences between groups that entered the COVID-19 process with risk factors and groups that did not report any risk factors. This situation is considered as an indication that entering into a new obscurity with unresolved issues affects the dynamics more negatively. © 2022 The Author(s).
ABSTRACT
BACKGROUND AND AIM: The purpose of the study was to examine the host risk factors related to mortality in patients hospitalized with coronavirus disease 2019 (COVID-19) pneumonia and to find a COVID-19 mortality score based on these factors. METHODS: Subjects hospitalized with COVID-19 pneumonia between March 11, 2020, and October 1, 2020, were retrospectively analyzed. The age, gender, smoking status, body mass index, blood group, severity of pneumonia, comorbidity, reverse transcriptase-polymerase chain reaction positivity, use of angiotensin-converting enzyme (ACE) inhibitors, radiological changes, and mortality rates of the patients who had proven COVID-19 pneumonia were recorded. Patients were divided into two groups according to mortality status, and the two groups were compared. The cutoff values, sensitivity and specificity values, and odds ratios were calculated to predict mortality of the new scoring system. RESULTS: A total of 422 patients (51 mortal and 371 nonmortal) participated in the study. The univariate regression analysis showed that age, male gender, smoking, comorbidity, and using ACE inhibitors were prognostic host risk factors for COVID-19-related mortality. A new scoring model with the combination of risk factors named Co-AMSCA was created in the study. The cutoff value of the system was found to be 3.5 with 88.4% sensitivity and 65.5% specificity. The mortality risk in patients with a Co-AMSCA mortality score above 3.5 points was 7.8 times higher than that in patients whose score was lower than 3.5 points. In multivariate logistic regression analysis, older age and smoking were significant risk factors for mortality. CONCLUSIONS: A mortality score was created based on host risk factors, which are easy to calculate and do not need laboratory tests and do not waste the time of the clinicians. This study showed that by using Co-AMSCA scoring model, it is possible to achieve a mortality prediction in COVID-19 patients who are hospitalized due to pneumonia.
ABSTRACT
Aim: The recommendation to avoid general anesthesia in pregnant women with coronavirus disease-2019 (COVID-19) and to use neuraxial blockade techniques, if possible, has not changed over time. On the other hand, general anesthesia also has to be applied to some patients in clinical practice. In this study, we evaluated anesthesia management, maternal outcomes, and clinical course in pregnant women with COVID-19 who delivered by cesarean section. Method(s): One hundred and seven pregnant women with COVID-19 who underwent cesarean sections between October 2020 and April 2021 were included in the study. Anesthesia methods, presenting symptoms, comorbidities, laboratory test results, and radiological data at admission, length of hospital stay, intensive care unit admissions, and mortality rates were retrospectively analyzed. Result(s): Out of 107 pregnant women, 85 underwent cesarean surgery under spinal anesthesia and 22 under general anesthesia. Forty patients (37%) had at least one symptom, whereas sixty-seven (63%) had no symptoms at all. Fifty percent of symptomatic and only 6% of asymptomatic pregnant women were admitted to the intensive care unit, and there was a significant difference between them. Mortality was 30% in symptomatic patients and only 1% in asymptomatic patients, and the difference in mortality was significant (p<0.05). Conclusion(s): Since the risk of intensive care and mortality is higher, particularly in symptomatic pregnant women with COVID-19, these patients should be evaluated, operated and followed up by experienced teams. Copyright © 2022 by The Medical Bulletin of Istanbul Haseki Training and Research Hospital The Medical Bulletin of Haseki published by Galenos Yayinevi.
ABSTRACT
The COVID-19 disease - which emerged in Wuhan, China in December 2019 - has had a significant effect on the whole world having developed into a pandemic, with a wide range of symptoms ranging from asymptomatic carrier to mortality. The focus on COVID-19 diagnosis for these reasons has led to difficulties in the diagnosis and treatment of other diseases. Vasculitis is a very difficult disease group due to its multi-organ involvement and different clinical courses. Due to its radiological properties, there the differential diagnosis of COVID-19 can be difficult. A 65-year-old female patient was admitted with a complaint of dry cough, shortness of breath when walking and chest pain. The patient was examined many times for COVID-19, both in our hospital and in other clinics, and for this reason, the diagnosis of vasculitis was delayed. A diagnosis of vasculitis should be kept in mind in patients with prolonged and multi-systemic symptoms when examined with a pre-diagnosis of COVID-19.